Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10557-015-6592-7.

Title:
Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart | Cardiovascular Drugs and Therapy
Description:
The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

article, pubmed, google, scholar, cas, angiotensin, receptor, heart, cardiac, cardiovasc, wang, glp, liraglutide, linagliptin, physiol, peptide, cardiovascular, drugs, myocardial, glucagonlike, fibrosis, central, iiinduced, angiotensinconverting, enzyme, control, collagen, ther, university, shanxi, privacy, cookies, content, research, tissue, expression, zhao, ang, ace, access, fibroblasts, inhibitors, res, inflammation, remodeling, circ, medicine, publish, search, preservation,

Topics {✒️}

ii-induced cardiac fibrosis zhi-qing zhao angiotensin-converting enzyme inhibitors month download article/chapter locally-expressed at1 receptor related subjects 288 ± 19 rfu/min/μg protein repressing nuclear factor-kappa transforming growth factor-beta1 smaller collagen-rich area reduced at1/at2 ratio α-sma expressing myofibroblasts xue-fen pang ning-ping wang dipeptidyl peptidase-4 inhibitors xue-wen li extracellular signal-regulated kinase ameliorates cardiac dysfunction myocardial ischemia-reperfusion injury full article pdf article cardiovascular drugs chronic heart failure angiotensin ii revisited diet-induced obesity ahmed ijaz shah angiotensin receptor blockers experimental heart failure at2 receptors privacy choices/manage cookies ang ii infusion cardioprotective effects mediated exert cardioprotective effects protein level mol cell cardiol enhanced at2 receptor article zhang dipeptidyl peptidase-4 improve coronary haemodynamics glp-1 receptor expression glp-1 receptor localization renin-angiotensin system tissue fibrosis peptide-1 access smad-dependent pathways myocardial ischemia/reperfusion cardiac fibrosis european economic area physiol endocrinol metab pressure dependent ischemic heart disease

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart
         description:The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
         datePublished:2015-05-21T00:00:00Z
         dateModified:2015-05-21T00:00:00Z
         pageStart:243
         pageEnd:255
         sameAs:https://doi.org/10.1007/s10557-015-6592-7
         keywords:
            Angiotensin II receptors
            ACE2
            Collagen
            Cardiac fibrosis
            Dipeptidyl peptidase-4
            Glucagon-like peptide-1
            Cardiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig8_HTML.gif
         isPartOf:
            name:Cardiovascular Drugs and Therapy
            issn:
               1573-7241
               0920-3206
            volumeNumber:29
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Li-Hui Zhang
               affiliation:
                     name:Shanxi Medical University, Shanxi Dayi Hospital
                     address:
                        name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xue-Fen Pang
               affiliation:
                     name:Shanxi Medical University
                     address:
                        name:Department of Physiology, Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feng Bai
               affiliation:
                     name:Shanxi Medical University, Shanxi Dayi Hospital
                     address:
                        name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ning-Ping Wang
               affiliation:
                     name:Mercer University School of Medicine
                     address:
                        name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ahmed Ijaz Shah
               affiliation:
                     name:Mercer University School of Medicine
                     address:
                        name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Robert J. McKallip
               affiliation:
                     name:Mercer University School of Medicine
                     address:
                        name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xue-Wen Li
               affiliation:
                     name:Shanxi Medical University, Shanxi Dayi Hospital
                     address:
                        name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiong Wang
               affiliation:
                     name:Shanxi Medical University, Shanxi Dayi Hospital
                     address:
                        name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhi-Qing Zhao
               affiliation:
                     name:Shanxi Medical University
                     address:
                        name:Department of Physiology, Shanxi Medical University, Taiyuan, China
                        type:PostalAddress
                     type:Organization
                     name:Mercer University School of Medicine
                     address:
                        name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart
      description:The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
      datePublished:2015-05-21T00:00:00Z
      dateModified:2015-05-21T00:00:00Z
      pageStart:243
      pageEnd:255
      sameAs:https://doi.org/10.1007/s10557-015-6592-7
      keywords:
         Angiotensin II receptors
         ACE2
         Collagen
         Cardiac fibrosis
         Dipeptidyl peptidase-4
         Glucagon-like peptide-1
         Cardiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig8_HTML.gif
      isPartOf:
         name:Cardiovascular Drugs and Therapy
         issn:
            1573-7241
            0920-3206
         volumeNumber:29
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Li-Hui Zhang
            affiliation:
                  name:Shanxi Medical University, Shanxi Dayi Hospital
                  address:
                     name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xue-Fen Pang
            affiliation:
                  name:Shanxi Medical University
                  address:
                     name:Department of Physiology, Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feng Bai
            affiliation:
                  name:Shanxi Medical University, Shanxi Dayi Hospital
                  address:
                     name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ning-Ping Wang
            affiliation:
                  name:Mercer University School of Medicine
                  address:
                     name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ahmed Ijaz Shah
            affiliation:
                  name:Mercer University School of Medicine
                  address:
                     name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Robert J. McKallip
            affiliation:
                  name:Mercer University School of Medicine
                  address:
                     name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xue-Wen Li
            affiliation:
                  name:Shanxi Medical University, Shanxi Dayi Hospital
                  address:
                     name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiong Wang
            affiliation:
                  name:Shanxi Medical University, Shanxi Dayi Hospital
                  address:
                     name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhi-Qing Zhao
            affiliation:
                  name:Shanxi Medical University
                  address:
                     name:Department of Physiology, Shanxi Medical University, Taiyuan, China
                     type:PostalAddress
                  type:Organization
                  name:Mercer University School of Medicine
                  address:
                     name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cardiovascular Drugs and Therapy
      issn:
         1573-7241
         0920-3206
      volumeNumber:29
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Shanxi Medical University, Shanxi Dayi Hospital
      address:
         name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
         type:PostalAddress
      name:Shanxi Medical University
      address:
         name:Department of Physiology, Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:Shanxi Medical University, Shanxi Dayi Hospital
      address:
         name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
         type:PostalAddress
      name:Mercer University School of Medicine
      address:
         name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
         type:PostalAddress
      name:Mercer University School of Medicine
      address:
         name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
         type:PostalAddress
      name:Mercer University School of Medicine
      address:
         name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
         type:PostalAddress
      name:Shanxi Medical University, Shanxi Dayi Hospital
      address:
         name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
         type:PostalAddress
      name:Shanxi Medical University, Shanxi Dayi Hospital
      address:
         name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
         type:PostalAddress
      name:Shanxi Medical University
      address:
         name:Department of Physiology, Shanxi Medical University, Taiyuan, China
         type:PostalAddress
      name:Mercer University School of Medicine
      address:
         name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Li-Hui Zhang
      affiliation:
            name:Shanxi Medical University, Shanxi Dayi Hospital
            address:
               name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Xue-Fen Pang
      affiliation:
            name:Shanxi Medical University
            address:
               name:Department of Physiology, Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Feng Bai
      affiliation:
            name:Shanxi Medical University, Shanxi Dayi Hospital
            address:
               name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Ning-Ping Wang
      affiliation:
            name:Mercer University School of Medicine
            address:
               name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
               type:PostalAddress
            type:Organization
      name:Ahmed Ijaz Shah
      affiliation:
            name:Mercer University School of Medicine
            address:
               name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
               type:PostalAddress
            type:Organization
      name:Robert J. McKallip
      affiliation:
            name:Mercer University School of Medicine
            address:
               name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
               type:PostalAddress
            type:Organization
      name:Xue-Wen Li
      affiliation:
            name:Shanxi Medical University, Shanxi Dayi Hospital
            address:
               name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Xiong Wang
      affiliation:
            name:Shanxi Medical University, Shanxi Dayi Hospital
            address:
               name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
               type:PostalAddress
            type:Organization
      name:Zhi-Qing Zhao
      affiliation:
            name:Shanxi Medical University
            address:
               name:Department of Physiology, Shanxi Medical University, Taiyuan, China
               type:PostalAddress
            type:Organization
            name:Mercer University School of Medicine
            address:
               name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
      name:Department of Physiology, Shanxi Medical University, Taiyuan, China
      name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
      name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
      name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
      name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
      name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
      name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
      name:Department of Physiology, Shanxi Medical University, Taiyuan, China
      name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(151)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.58s.